E. N. COLLINS, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
During the past three years, sulfanilamide and its derivatives, such as neoprontosil and more recently sulfapyridine, have been used in the treatment of chronic ulcerative colitis. In this disease several types of organisms are commonly isolated from rectal scrapings and stools. When the same types of organisms are the cause of disease in other parts of the body, the use of the chemotherapeutic agents mentioned has proved valuable in certain instances. Therefore, it seems logical that patients having chronic ulcerative colitis, a serious and disabling disease, should be given the benefit of a trial on this form of therapy.
COLLINS EN. THE TREATMENT OF CHRONIC ULCERATIVE COLITIS WITH SULFANILAMIDE1. Ann Intern Med. ;14:55–64. doi: 10.7326/0003-4819-14-1-55
Download citation file:
Published: Ann Intern Med. 1940;14(1):55-64.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use